Mos Mo

HwaGen Qingyan is a spin-off from Tsinghua University Shenzhen Graduate School and a joint venture invested by HwaGen, a CRO for small molecule R&D, main responsibilities include: 1. Research and business strategy development for HwaGen Qingyan to fulfil the value proposition as a public new drug R&D platform for academia and industry; 2. Team optimization and new team setup, core team recruitment; 3. External technology partner scouting and develop partnership to form a complete platform enabling AIDD for new molecule design; Chemical Synthesis; Biology assay for in vitro/ in vivo study; 4. Lead and execute research projects from collaborative partner and in-house R&D idea.

Leading the public service platform of innovative drug discovery and development integrating AIDD tools and scientists' expertise with biology experiments to accelerate R&D productivity and efficiency.

A complete new business model for a pharmaceutical company to develop external innovation. Main responsibilities included: 1. Strategy development and initial execution: strategy concept for BIC integrating multiple business model for short term/mid-term and long term development: early incubation and investment; CRO service and space rental for tenants. 2. Early stage new drug development project scouting from universities and research institutes and Biotech;

A start-up-like sector in Merck, leading a small pioneering team of 4 in Merck Guangdong (GD) Innovation Hub (@Bio-island, Guangzhou) for operation, strategic partnership development, project scouting and incubation in Life Science, Biopharma and Materials. 1. Connect innovative partners including gov. /related bodies, incubators, start-ups, venture capital, academia, consultant & media for strategic partnering model to search and support high potential start-ups for incubation. 2. Develop innovation pipeline. Conduct comprehensive market research and explore the external project synergy level with Merck, identify Merck business sector's core capabilities and resources to support incubated projects; complete project due diligent and evaluation. 3. Key initiatives: 1) Design, plan & execute of Merck GD Innovation Hub Grand Opening. Key participants including Guangzhou municipal and GDD level officers, 200 key opinion leaders from ChinaGreater Bay Area innovation eco-system. 2) Online/offline Industrial forum with GDD, Biologics QC Association, HKSTP, Tongxieyi, GD Medical Valley, Healthcare Drink, Yuexiu Industrial Fund accumulated over 80,000 audience and successfully enrolled GD Hub’s 1st innovative project in RNA sample collection and detection of COVID-19 rapid testing. 3) Lead a 6-month consultation project- China Greater Bay Area Innovation Landscape Market Research and White Paper (PwC Strategy & team as external consultant support) via industrial foundation research and interview with key stakeholders in the ecosystem to advocate multi-government bodies and Merck China Life Science for co-development of a true open public service platform to cultivate high potential innovative Emerging Biotech. A more detailed platform execution plan is developing for internal and external communication and project execution.

1.Manage full Life Science: Bioprocess+Research & Applied market by leveraging direct sales team(of 4 sales rep.) and distribution channel for annual US$30 million business. 2. Defend market share as a marker leader for core technology in protein purification solution while seek growth in NPS:Single Use Bioprocess technology, Cell Culture technology, Cell Therapy and Enterprise Solution Flex factory, KuBio 3. Cross-function communication from customer services, supply chain, finance, HR to ensure operation and commercial excellent.

1. Build up Asia Lab marketing platform and foundation as bridge communicate between Asia-globe 2. Strategic and tactic marketing planning and execution to align with global laboratory marketing plan 3. As ambassador of Pall lab technology aim at improving technical competency for Pall sales team and promote Pall lab’s core technology value to customers. 4. Engagement programs. Build up team connection, increase team morale, share good practice and replicate the success. 5. Smart marketing approach by e-commerce and leveraging channel partners' resources with <$100K to market a double digit million business.

Leading a small but dynamic team of 6 to cover South East Asia(TW,SG,MY,ID,TH) Lab business. 1. Achieve YoY two-digit growth sales target by KAM (esp. in Academia, Pharma, FnB, Testing Lab) 2. Distribution network development in emerging countries. 3. Holistic cross-function communication with customer service, supply chain, finance, HR, marketing to ensure smooth operational workflow. 4. Initiating and executing Annual Sales & Budgeting Plan and P&L for the team.

1, Channel optimization to improve coverage. Focus on untapped market Yunnan, Sichuan, Guizhou 2. Business development in new application and upcoming opportunity for IVD R&D, Pharmaceutical QC, Micro Eletronics, PM2.5 and Labwater. 3. Sub-dealer network improvement to better penestrate different mini-market (Analytical QC, LS Research, Enviormental QC) 4. Major distributor managment: KAM, inventory Achievements: Continuous 100% YoY growth for last consecutive 3 fiscal years Build up a more complex distribution network (master-secondary-dealer)

Overseas market business development ( US/Europe/APAC) for this pioneer Synthesis Biology Startup in China, mainly focus on DNA synthesis Service to Research Institutes and Pharmaceuticals.

A part-time program from Yeehong Business School (under Shenyang Pharmaceutical University) focusing on New Drug R&D from Drug discovery to registration including small molecules and large molecules. Real case study and project presentation, KOL forum and company visitation in focus biotech clusters Shanghai, Suzhou, Beijing.

Full time MBA program. Projects during MBA program: 1. ICSP (Integrated China Strategy Program) Team leader: Market entry strategy in private health insurance for innovative biologic drugs in MNC biopharmaceuticals 3 mos 2. Business Development Consultant in EcoGene( New Startup of Next Generation Sequencing reagents and consumables) 6 mos 3. CHIP (China Healthcare Innovation Platform) Core team: leading Biotech and IVD cases screening and communication with corporates for the proposed business plans